Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer

Ester Lara1, Vincenzo Calvanese, Covadonga Huidobro

  • 1Department of Immunology and Oncology, National Center for Biotechnology, CNB-CSIC, Cantoblanco, Madrid E-28049, Spain.

Molecular Cancer
|July 2, 2010
PubMed
Abstract

Insights

Aberrant methylation of ROR2, a non-canonical Wnt pathway receptor, is frequent in colon cancer. Its loss promotes tumors by impacting canonical Wnt signaling, revealing a crucial link between Wnt pathways in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Wnt signaling pathways, canonical (beta-catenin-dependent) and non-canonical (beta-catenin-independent), regulate cell differentiation.
  • Alterations in canonical Wnt signaling are key drivers of colon cancer.
  • The role of non-canonical Wnt pathways in tumorigenesis is not well understood.

Purpose of the Study:

  • Investigate the role of the non-canonical Wnt receptor ROR2 in colon cancer.
  • Determine the mechanisms of ROR2 regulation in colon cancer.
  • Explore the interplay between canonical and non-canonical Wnt pathways in colon cancer.

Main Methods:

  • Analysis of ROR2 promoter methylation in colon cancer cell lines and primary tumors.
  • Restoration of ROR2 activity in colon cancer cells.
  • Assessment of Wnt pathway activation following ROR2 restoration.

Main Results:

  • ROR2 is frequently repressed by promoter hypermethylation in colon cancer.
  • Restoring ROR2 activity in cancer cells impacts canonical Wnt signaling.
  • Epigenetic silencing of ROR2 is pro-tumorigenic in colon cancer.

Conclusions:

  • Epigenetic repression of ROR2 is a significant event in colon cancer.
  • ROR2's function in colon cancer involves canonical Wnt signaling.
  • This study highlights the interconnection between canonical and non-canonical Wnt pathways in colon cancer.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...